•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Bank of New York Mellon Corp Sells 36,570 Shares of Caesars Entertainment, Inc. $CZR
Why Fast-paced Mover Caesars Entertainment (CZR) Is a Great Choice for Value Investors
Savor 60 Years of Caesars Palace with Limited-Time Dining and Cocktail Experiences Inspired by 1966
Caesars Entertainment (CZR) Earnings Expected to Grow: Should You Buy?
U.S. Consumer Sentiment Index Hits Five-Month High: 5 Top Picks
July's 5 Dividend Growth Stocks With Yields Up To 6.85%
Caesars Entertainment Releases 2025 Corporate Social Responsibility Report Highlighting Efforts in Community Impact, Environmental Stewardship, Responsible Gaming and More
Here Are Thursday's Best Wall Street Analyst Research Calls: Align Technology, American Tower, Caesars Entertainment, Cohu, Five Below, Intuitive Surgical, Salesforce, Toast, and More
Caesars Republic Lake Tahoe is Officially Open Debuting a Bold New Era of Luxury on the South Shore
Bear of the Day: Caesars Entertainment (CZR)
Caesars vs. Six Flags: Which Leisure Entertainment Stock Is a Better Buy in 2026?
Caesars Entertainment, Inc. to Report 2026 Second Quarter Results on July 28, 2026
New Strong Sell Stocks for July 1st
Caesars Entertainment and Three Wabanaki Nations Expand Relationship to Include Planned Maine Online Casino Launch
CZR Exchange Surpasses 100,000 Users in Six Months as Anticipation Builds for the CZR Token Launch
Here Are Monday's Best Wall Street Analyst Research Calls: Accenture, Caesars Entertainment, Datadog, Dupont, Epam Systems, Ferrari, Paychex, Rocket Lab, TeraWulf, and More
Are GBTG, INM, CZR, TMHC Obtaining Fair Deals for their Shareholders?
A New Jewel on the Las Vegas Strip: Lisa Vanderpump Celebrates Grand Opening of The Vanderpump Hotel
Shareholder Alert: Ademi LLP investigates whether Caesars Entertainment, Inc. is obtaining a Fair Price for Public Shareholders
The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—TMHC, CZR, XOMA, and AVNS